Over the past few years, authoritative, trustworthy guidance for the clinical translation of artificial intelligence (AI) has formed mainly around two areas: responsible model development and validation; and prospective clinical trials. Initial work focused on building a good model, which generally means a model that demonstrates good performance, addresses an important clinical task, trains on the right data to address that task and could be used for some meaningful goal1. The model should […]
CANAIRI: the Collaboration for Translational Artificial Intelligence Trials in healthcare